EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combined Administration of Lactobacillus or Bifidobacterium Offers Enhanced Antidepressant and Anxiolytic Activity in a Dose Dependent Manner

Aliu Zanzeh Bankah, Thomas Amatey Tagoe iD, Emmanuel Darko, Righteous Agoha, Elmer Nayra Ametefe, Kennedy Kwami Edem Kukuia iD, Samuel Adjei iD

Brain and Behavior · 2025

DOI: 10.1002/brb3.70564 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Behavior, 2025. Verfasst von Aliu Zanzeh Bankah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, University of Ghana, Legon, Ghana. Hauptthemen laut MEDLINE: Probiotics, Depression, Anxiety, Bifidobacterium. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Gut microbiota is strongly linked to the activity of the bidirectional gut‐brain axis, which influences neuropsychological processes at multiple levels. Changes in the gut microbiota have been implicated in mood disorders, and probiotics have been explored for their ability to mitigate the effects of stress on mental health. Here, we investigated the therapeutic benefits of different concentrations and combinations of Lactobacillus and Bifidobacterium in a mouse model of stress induced depression and anxiety.

Methods

Sixty‐three male ICR mice (6–8 weeks old; 20–25g) divided into nine groups were used for this study. The test groups underwent chronic unpredictable mild stress protocols for two weeks before receiving low (10 4 CFU/ml) or high (10 8 CFU/ml) doses of either monotherapy ( Lactobacillus or Bifidobacterium ) or a combination therapy ( Lactobacillus and Bifidobacterium ) for four weeks. The antidepressant, fluoxetine, served as the positive control. Measurements of weight and sucrose preference were performed at four time points in addition to a battery of behavioral tests (open field tests, forced swim test, tail suspension test, and hot plate test) at the endpoint to assess depression and anxiety‐like behavior.

Results

Low doses of the probiotic formulation (mono‐ or combined therapy) reversed weight loss but not anhedonia. In contrast, high doses of probiotic formulations (mono‐ or combined therapy), along with fluoxetine, were effective in reversing the weight loss and anhedonia caused by chronic unpredictable mild stress. Probiotics ameliorated stress‐induced immobility as measured by both the forced swim and tail suspension tests, while also reducing anxiety‐like behavior (increased peripheral activity) in the open field test. High doses of mono‐ or combined therapy increased curling behavior in the tail suspension test, whereas fluoxetine failed to do so.

Conclusion

This study indicates the species‐ and dose‐dependent beneficial effects of probiotics on behavioral outcomes associated with depression while also reversing weight loss. Evidence suggests that probiotics and fluoxetine may exert antidepressant activity via different mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsDepressionAnxietyBifidobacteriumLactobacillusAntidepressive AgentsAnti-Anxiety AgentsAnimalsMaleMiceMice, Inbred ICRDisease Models, AnimalStress, PsychologicalBehavior, AnimalGastrointestinal MicrobiomeFluoxetine

Stichwörter der Autor:innen

gut microbiomelactic acid bacteriamental healthprobiotics

Substanzen

Antidepressive AgentsAnti-Anxiety AgentsFluoxetine

Autor:innen und Institutionen

  • Department of Physiology, University of Ghana, Legon, Ghana.
  • Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Legon, Ghana.
  • Department of Medical Pharmacology, University of Ghana, Legon, Ghana.
  • Department of Animal Experimentation, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.

ORCID-Profile: Thomas Amatey Tagoe, Kennedy Kwami Edem Kukuia, Samuel Adjei

Zitieren

APA

Bankah, A. Z., Tagoe, T. A., Darko, E., Agoha, R., Ametefe, E. N., Kukuia, K. K. E., & Adjei, S. (2025). Combined Administration of Lactobacillus or Bifidobacterium Offers Enhanced Antidepressant and Anxiolytic Activity in a Dose Dependent Manner. Brain and Behavior. https://doi.org/10.1002/brb3.70564

Vancouver

Bankah AZ, Tagoe TA, Darko E, Agoha R, Ametefe EN, Kukuia KKE, et al. Combined Administration of Lactobacillus or Bifidobacterium Offers Enhanced Antidepressant and Anxiolytic Activity in a Dose Dependent Manner. Brain and Behavior. 2025. doi:10.1002/brb3.70564

BibTeX
@article{Bankah2025,
  author = {Bankah, Aliu Zanzeh and Tagoe, Thomas Amatey and Darko, Emmanuel and Agoha, Righteous and Ametefe, Elmer Nayra and Kukuia, Kennedy Kwami Edem and Adjei, Samuel},
  title = {Combined Administration of Lactobacillus or Bifidobacterium Offers Enhanced Antidepressant and Anxiolytic Activity in a Dose Dependent Manner},
  journal = {Brain and Behavior},
  year = {2025},
  doi = {10.1002/brb3.70564}
}
Kostenlos starten →